Eddingpharm (Cayman) Inc. and Chiesi Farmaceutici SpA Form Asthma Drug JV
4/16/2013 9:08:36 AM
More...
|
Cornerstone Therapeutics Inc. Acquires Exclusive U.S. Rights to Chiesi Farmaceutici SpA's BETHKIS® (Tobramycin Inhalation Solution)
11/8/2012 9:21:39 AM
More...
|
Veloxis Pharmaceuticals A/S (VELO), Chiesi Farmaceutici SpA Ink $47.5 Million Pact
10/5/2012 7:02:49 AM
More...
|
Kamada Ltd. (KMDA.TA) and Chiesi Farmaceutici SpA Enter into a Strategic Agreement for Up to $60 Million
8/6/2012 8:07:26 AM
More...
|
Galapagos NV (GLPG.BR) Announces Second Extension to Services Collaboration with Chiesi Farmaceutici SpA
10/12/2011 8:22:26 AM
More...
|
Chiesi Farmaceutici SpA Implements Cegedim SA Relationship Management Mobile Intelligence(TM) Software as a Service (SaaS) CRM Solution
10/11/2011 11:50:48 AM
More...
|
NiKem Research and Chiesi Farmaceutici SpA Extend Research Collaboration
9/6/2011 11:18:58 AM
More...
|
Galapagos NV (GLPG.BR)' Affiliate BioFocus DPI Extends Collaboration with Chiesi Farmaceutici SpA
10/14/2010 9:25:58 AM
More...
|
Chiesi Farmaceutici SpA Relies on QUMAS to Manage Documentation for Regulatory Submissions
3/16/2010 10:32:46 AM
More...
|
Phenomix Corporation Grants Chiesi Farmaceutici SpA European Rights to Dutogliptin for Diabetes in Deal Worth Up to $191 Million
12/2/2009 9:03:47 AM
More...
|
|